You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Attention Score in Context
| Title |
テーマ:リスクが潜む医薬品の個人輸入:偽造医薬品だけにとどまらない危険性
|
|---|---|
| Published in |
Japanese Journal of Social Pharmacy, February 2017
|
| DOI | 10.14925/jjsp.35.2_108 |
| Authors |
高梨 宏, 岡沢 宏美, 相原 史子, 古賀 達郎, 橋本 啓一, 渡辺 朋子 |
X Demographics
The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Japan | 2 | 67% |
| Unknown | 1 | 33% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 3 | 100% |
Attention Score in Context
This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 20 August 2021.
All research outputs
#15,379,802
of 25,852,155 outputs
Outputs from Japanese Journal of Social Pharmacy
#21
of 60 outputs
Outputs of similar age
#174,230
of 325,134 outputs
Outputs of similar age from Japanese Journal of Social Pharmacy
#1
of 2 outputs
Altmetric has tracked 25,852,155 research outputs across all sources so far. This one is in the 40th percentile – i.e., 40% of other outputs scored the same or lower than it.
So far Altmetric has tracked 60 research outputs from this source. They receive a mean Attention Score of 3.1. This one has gotten more attention than average, scoring higher than 63% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 325,134 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 46th percentile – i.e., 46% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 2 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them